Skip to main content

News / Articles

Financing the Medtech Journey: From Innovation to Commercialization by LeagueMed

A new whitepaper from the founders of LeagueMed provides a practical overview of how to transform early-stage MedTech innovations into viable companies. The paper, titled “Financing the Medtech Journey: From Innovation to Commercialization” details the foundational steps of company formation, licensing, product development, and clinical trials, as well as the funding strategies that drive growth in sectors such as pharmaceuticals, medical devices, and digital health.
 
Key Takeaways
  • LeagueMed's whitepaper outlines steps for transforming MedTech innovations into viable companies, focusing on company formation, licensing, and product development.
  • The National Institutes of Health is highlighted as a major early funding source, crucial for technology transfer and company formation.
  • Understanding clinical pathways and funding sources is essential for MedTech startups to navigate the complex journey from innovation to commercialization.
  • LeagueMed provides advisory services to help healthcare professionals and startups overcome financial and commercialization challenges in the MedTech sector.
Learn more